GET DAILY SIGNALSVentas (VTR) vs Welltower (WELL): Two Senior Housing REITs Compared
Key Takeaways
- VTR (Ventas) and WELL (Welltower) are both major healthcare real estate investment trusts focused on the senior housing sector, yet they differ notably in size, growth trajectory, valuation, and dividend yield.
- Tickeron AI Verdict: Based on trend consistency, momentum, balance-sheet strength, and operating catalysts, Tickeron’s AI currently favors WELL over VTR in this comparison.
- Welltower is showing stronger same-store net operating income (NOI) growth and higher funds from operations (FFO) expansion, while Ventas provides a higher dividend yield at a lower valuation multiple.
- For the latest updates, check VTR Major News and VTR Today's Price Move, or WELL Major News and WELL Today's Price Move.
- To see how AI trading bots are positioned across these and other tickers, explore the Trending AI Robots.
Introduction
Ventas, Inc. and Welltower, Inc. rank among the largest publicly traded healthcare REITs, both set to benefit from the same demographic shift: an aging Baby Boomer population boosting demand for senior housing. Because the two operate in similar markets and track comparable metrics, investors often compare them directly. This analysis looks at their recent performance, growth drivers, balance-sheet positions, and market stance. It should be useful for income-oriented investors focused on healthcare real estate as well as growth-minded traders evaluating momentum and consistency in the current environment.
VTR Overview and Recent Performance
Ventas, Inc. (VTR) is a Chicago-based healthcare REIT with approximately 1,450 properties in North America and the United Kingdom. Its holdings center on a senior housing operating portfolio (SHOP), along with outpatient medical and research buildings plus triple-net leased assets. In the most recent quarter, Ventas posted third-quarter normalized funds from operations (FFO) of $0.99 per share, up roughly 10% from a year earlier, on revenue of $1.83 billion, a 23% rise. Same-store cash NOI in the senior housing segment increased 15.5%, helped by a 290-basis-point occupancy gain to 92.1% and a 5% rise in revenue per occupied room. The company has acquired more than $5 billion in senior housing assets year to date and lowered its net-debt-to-adjusted-EBITDA leverage to 4.4 times. Management lifted full-year normalized FFO guidance to a range of $3.87 to $3.90 per share.
WELL Overview and Recent Performance
Welltower, Inc. (WELL) is a Toledo, Ohio-based healthcare infrastructure REIT that positions itself at the center of the silver economy, with more than 2,500 seniors and wellness housing communities in the United States, United Kingdom, and Canada. In its latest quarter, Welltower reported normalized FFO of $1.67 per share, with revenue up about 38% year over year and adjusted EBITDA up roughly 35%. Total portfolio same-store NOI rose 15.8%, led by a 21% increase in its seniors housing operating segment—its sixteenth straight quarter of at least 20% same-store growth. Occupancy improved 320 basis points and revenue per occupied room accelerated to 5.3%. The company raised its full-year normalized FFO midpoint to $6.50 per share, pointing to about 23% growth, and increased its quarterly dividend 15% to $0.85 per share.
Head-to-Head Comparison
While both companies benefit from the same demographic trends, their market positions differ in several respects. WELL is roughly three times the size of Ventas by market capitalization and is expanding operating income more rapidly, with same-store NOI growth of 15.8% versus about 10.6% for VTR. Welltower also maintains a stronger balance sheet, with net-debt-to-adjusted-EBITDA near 3.0 times compared with about 4.4 times for Ventas, and it holds a lower payout ratio even after raising its dividend. In contrast, VTR trades at a lower valuation and delivers a higher dividend yield—around 2.4% versus roughly 1.4% for Welltower. Ventas offers greater revenue diversification through its outpatient medical, research, and triple-net segments, whereas Welltower is more concentrated in senior housing operations. Both face interest-rate sensitivity and tenant concentration risks, while Welltower’s higher valuation leaves it more exposed to multiple compression should growth slow.
Tickeron AI Verdict
Considering factors such as trend consistency, operating momentum, balance-sheet strength, and the clarity of near-term catalysts, Tickeron’s AI currently leans toward WELL in this comparison. The view rests on Welltower’s sustained double-digit same-store NOI growth, faster FFO expansion, lower leverage, and a recently raised dividend that reflects management confidence. VTR remains an attractive income option with its higher yield and more diversified cash flows, yet its slower growth and higher leverage put it at a relative disadvantage on momentum-based signals. This assessment reflects current conditions and could shift with new information.
Using AI Tools in Research
When comparing names like these, I often run quick checks through Tickeron’s AI Screener to see how each stacks up against peers on key metrics.
Exploring AI Trading Bots
In my own work, I find it useful to review Tickeron’s Trending AI Robots to understand how automated strategies are currently positioned across healthcare REITs and thousands of other tickers. The selection highlights bots with favorable recent statistics that align with prevailing market conditions, offering a data-driven way to evaluate potential automated approaches.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
VTR's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for VTR turned positive on October 13, 2026. Looking at past instances where VTR's MACD turned positive, the stock continued to rise in 28 of 38 cases over the following month. The odds of a continued upward trend are 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VTR's RSI Indicator exited the oversold zone, 19 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on VTR as a result. In 54 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
Following a +3.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where VTR advanced for three days, in 202 of 334 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
VTR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
The Aroon Indicator for VTR entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 24 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. VTR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.036) is normal, around the industry mean (3.125). VTR's P/E Ratio (157.673) is considerably higher than the industry average of (28.561). VTR's Projected Growth (PEG Ratio) (4.961) is slightly higher than the industry average of (1.649). Dividend Yield (0.024) settles around the average of (0.049) among similar stocks. P/S Ratio (6.605) is also within normal values, averaging (6.013).
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a real estate investment trust
Industry PublishingBooksMagazines
Advertisement